8-K Announcements
6Material company update
Jun 15, 2023·SEC
Material company update
Jun 9, 2023·SEC
Material company update
May 26, 2023·SEC
EUDA Health Holdings Limited(EUDA)Earnings, Financials & Key Ratios
EUDA•NASDAQ
Price updated Jun 19, 2026
AboutEUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.Show more
- Revenue$7M+70.0%
- EBITDA-$2M+88.1%
- Net Income-$3M+81.9%
- EPS (Diluted)-1.49+84.1%
- Gross Margin43.88%+130.9%
- EBITDA Margin-29.82%+93.0%
- Operating Margin-35.78%+91.7%
- Net Margin-40.65%+89.4%
EUDA Key Insights
EUDA Health Holdings Limited (EUDA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 89 (top 11%)
- ✓Efficient asset utilization: 4.0x turnover
✗Weaknesses
- ✗Negative free cash flow
- ✗Sales declining 5.1% over 5 years
- ✗Shares diluted 14.5% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when EUDA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
EUDA Price & Volume
EUDA Health Holdings Limited (EUDA) stock price & volume — 10-year historical chart
Loading chart...
EUDA Growth Metrics
EUDA Health Holdings Limited (EUDA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-5.13%
3 Years21.91%
TTM30.08%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM101.13%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM93.79%
Return on Capital
10 Years-541.56%
5 Years-576.11%
3 Years-
Last Year-
EUDA Recent Earnings
EUDA Health Holdings Limited (EUDA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 0/12 qtrs (0%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
Apr 28, 2026Metric
Actual
Est
EPS
$0.40+0.0%
$0.40
Rev
$6M-3.0%
$6M
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$0.40+0.0%
$0.40
Rev
$6M-3.0%
$6M
Q4 2025
Oct 1, 2025Metric
Actual
Est
EPS
—
$0.06
Rev
$3M-23.9%
$4M
Q3 2025
Jun 4, 2025Metric
Actual
Est
EPS
$0.32
—
Rev
$2M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 28, 2026 | $0.40vs $0.40+0.0% | $6Mvs $6M-3.0% |
| Q1 2026 | Feb 25, 2026 | $0.40vs $0.40+0.0% | $6Mvs $6M-3.0% |
| Q4 2025 | Oct 1, 2025 | —vs $0.06 | $3Mvs $4M-23.9% |
| Q3 2025 | Jun 4, 2025 | $0.32 | $2M |
Based on last 12 quarters of dataView full earnings history →
EUDA Peer Comparison
EUDA Health Holdings Limited (EUDA) competitors in Virtual Care and Digital Programs — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ACMR | 7.28B | 109.87 | 80.20 | 15.24% | 9.48% | 5.13% | 0.16 | |
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 | |
 TALK | 872.74M | 5.21 | 130.25 | 22% | 0.49% | 1.03% | ||
 OPRX | 93.45M | 4.98 | 18.44 | 18.78% | 6.37% | 5.47% | 0.20 | |
 WELL | 144.78B | 206.65 | 148.67 | 35.82% | 12.31% | 3.49% | 0.49 | |
 TDOC | 1.46B | 8.07 | -7.08 | -1.54% | -6.81% | -12.37% | 0.75 | |
 AMWL | 140.85M | 8.43 | -1.41 | -1.98% | -48.16% | -33.48% | 0.02 | |
 DOCS | 3.83B | 20.46 | 20.88 | 13.05% | 30.4% | 19.36% | 0.01 |
Compare EUDA vs Peers
EUDA Health Holdings Limited (EUDA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
EUDA Income Statement
EUDA Health Holdings Limited (EUDA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|
Sales/Revenue | 8.88M | 4.56M | 3.76M | 3.71M | 4.01M | 6.82M | 5.16M |
Revenue Growth % | - | -48.64% | -17.42% | -1.54% | 8.22% | 70.04% | 30.08% |
Cost of Goods Sold | 4.99M | 3.31M | 2.89M | 2.86M | 3.25M | 3.83M | 4M |
COGS % of Revenue | 56.17% | 72.58% | 76.89% | 77.28% | 81% | 56.12% | - |
Gross Profit | 3.89M▲ 0% | 1.25M▼ 67.9% | 870K▼ 30.4% | 842.08K▼ 3.2% | 762.15K▼ 9.5% | 2.99M▲ 292.7% | 1.16M▲ 0% |
Gross Margin % | 43.83% | 27.42% | 23.11% | 22.72% | 19% | 43.88% | 22.39% |
Gross Profit Growth % | - | -67.87% | -30.4% | -3.21% | -9.49% | 292.68% | - |
Operating Expenses | 4.78M | 1.81M | 13.09M | 4.8M | 18.1M | 5.43M | 3.28M |
OpEx % of Revenue | 53.9% | 39.71% | 347.72% | 129.59% | 451.19% | 79.66% | - |
Selling, General & Admin | 4.63M | 1.81M | 6.75M | 4.8M | 3.34M | 5.43M | 3.28M |
SG&A % of Revenue | 52.12% | 39.71% | 179.33% | 129.59% | 83.32% | 79.66% | - |
Research & Development | 158.01K | 129.26K | 17.21K | 0 | 0 | 249 | 244 |
R&D % of Revenue | 1.78% | 2.84% | 0.46% | - | - | 0% | - |
Other Operating Expenses | 0 | -129.26K | 6.32M | 0 | 14.76M | 0 | 0 |
Operating Income | -893.56K▲ 0% | -559.99K▲ 37.3% | -5.72M▼ 921.3% | -3.96M▲ 30.7% | -17.34M▼ 337.6% | -2.44M▲ 85.9% | -2.12M▲ 0% |
Operating Margin % | -10.07% | -12.28% | -151.93% | -106.87% | -432.19% | -35.78% | -41.13% |
Operating Income Growth % | - | 37.33% | -921.29% | 30.74% | -337.64% | 85.92% | - |
EBITDA | -669.44K | -295.89K | -5.46M | -3.85M | -17.16M | -2.03M | -1.99M |
EBITDA Margin % | -7.54% | -6.49% | -145.12% | -103.87% | -427.87% | -29.82% | -38.61% |
EBITDA Growth % | - | 55.8% | -1746.25% | 29.53% | -345.78% | 88.15% | 91.35% |
D&A (Non-Cash Add-back) | 224.12K | 264.1K | 256.26K | 111.2K | 173.22K | 406.48K | 129.76K |
EBIT | -893.56K | 1.08M | -24.81M | -8.41M | -17.6M | -2.5M | -2.12M |
Net Interest Income | -65.82K | 1.79M | -93.78K | -23.23K | -44.89K | -228.62K | -45.59K |
Interest Income | 0 | 1.92M | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 65.82K | 127.13K | 93.78K | 23.23K | 44.89K | 228.62K | 45.59K |
Other Income/Expense | 1.14M | 2.23M | -19.21M | -4.47M | -307.38K | -285.26K | 23.41K |
Pretax Income | 246.45K▲ 0% | 1.67M▲ 577.4% | -24.93M▼ 1593.5% | -8.43M▲ 66.2% | -17.64M▼ 109.2% | -2.73M▲ 84.5% | -2.1M▲ 0% |
Pretax Margin % | 2.78% | 36.62% | -662.32% | -227.57% | -439.85% | -39.97% | -40.67% |
Income Tax | 47.48K | 46.49K | -20.79K | 0 | -4.38K | 41.94K | 7.67K |
Effective Tax Rate % | 19.26% | 2.78% | 0.08% | 0% | 0.02% | -1.54% | -0.37% |
Net Income | 175.57K▲ 0% | 864.83K▲ 392.6% | -24.88M▼ 2977.3% | -10.04M▲ 59.7% | -15.36M▼ 53.0% | -2.77M▲ 81.9% | 266.67K▲ 0% |
Net Margin % | 1.98% | 18.97% | -661.06% | -270.86% | -382.87% | -40.65% | 5.17% |
Net Income Growth % | - | 392.57% | -2977.35% | 59.66% | -52.97% | 81.94% | 101.13% |
Net Income (Continuing) | 198.97K | 1.62M | -25.01M | -8.43M | -17.64M | -2.77M | -2.11M |
Discontinued Operations | 0 | -722.44K | 58.66K | -1.6M | 2.25M | 0 | 2M |
Minority Interest | 43.23K | 78.82K | 13.48K | 16.61K | -19.01K | -12.58K | -16.75K |
EPS (Diluted) | 0.47▲ 0% | 1.87▲ 294.5% | -41.40▼ 2313.9% | -8.80▲ 78.7% | -9.40▼ 6.8% | -1.49▲ 84.1% | 0.14▲ 0% |
EPS Growth % | - | 294.51% | -2313.9% | 78.74% | -6.82% | 84.15% | 93.79% |
EPS (Basic) | 0.47 | 1.87 | -41.40 | -7.40 | -9.40 | -1.49 | - |
Diluted Shares Outstanding | 371.11K | 462.67K | 601.48K | 1.15M | 1.62M | 1.86M | 1.86M |
Basic Shares Outstanding | 371.11K | 462.67K | 601.48K | 1.36M | 1.62M | 1.86M | 1.86M |
Dividend Payout Ratio | - | - | - | - | - | - | - |
EUDA Balance Sheet
EUDA Health Holdings Limited (EUDA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|
Total Current Assets | 4.27M | 4.35M | 25.03M | 723.44K | 762.88K | 1.04M | 1.31M |
Cash & Short-Term Investments | 250.77K | 190K | 57.54K | 189K | 237.6K | 345.14K | 176.58K |
Cash Only | 250.77K | 190K | 57.54K | 189K | 237.6K | 345.14K | 176.58K |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 1.61M | 4.09M | 192.85K | 239.19K | 170.27K | 334.2K | 426.69K |
Days Sales Outstanding | 66.41 | 327.35 | 18.7 | 23.55 | 15.49 | 17.89 | 20.69 |
Inventory | 0 | 0 | 648.16K | 0 | 128.98K | 2.84K | 116.84K |
Days Inventory Outstanding | - | - | 81.74 | - | 14.49 | 0.27 | 11.2 |
Other Current Assets | 2.35M | 2.8K | 24.12M | 295.25K | 226.03K | 357.18K | 71.54K |
Total Non-Current Assets | 1.61M | 3.65M | 602.56K | 587.07K | 967.34K | 677.2K | 816.01K |
Property, Plant & Equipment | 137.41K | 161.16K | 124.5K | 206.99K | 316.26K | 332.29K | 322.82K |
Fixed Asset Turnover | 64.59x | 28.29x | 30.24x | 17.91x | 12.68x | 20.52x | 16.15x |
Goodwill | 1.01M | 992.69K | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 461.29K | 289.96K | 0 | 0 | 337.3K | 161.43K | 260.37K |
Long-Term Investments | 0 | 2.2M | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 2.2M | 478.06K | 380.07K | 281.38K | 183.47K | 232.82K |
Total Assets | 5.88M▲ 0% | 8M▲ 36.1% | 25.63M▲ 220.4% | 1.31M▼ 94.9% | 1.73M▲ 32.0% | 1.72M▼ 0.8% | 2.12M▲ 0% |
Asset Turnover | 1.51x | 0.57x | 0.15x | 2.83x | 2.32x | 3.97x | 2.70x |
Asset Growth % | - | 36.07% | 220.4% | -94.89% | 32.01% | -0.78% | 38.89% |
Total Current Liabilities | 6.09M | 7.32M | 29.12M | 8.72M | 4.14M | 5.84M | 5.71M |
Accounts Payable | 1.48M | 2.82M | 1.46M | 1.29K | 25.89K | 14.15K | 316.51K |
Days Payables Outstanding | 108.13 | 311.01 | 184.3 | 0.16 | 2.91 | 1.35 | 15.6 |
Short-Term Debt | 657.17K | 353.73K | 3.57M | 3.17M | 1.04M | 2.2M | 2.06M |
Deferred Revenue (Current) | 0 | 0 | -3.69M | 0 | 477.92K | 522.03K | 477.92K |
Other Current Liabilities | 3.46M | 3.82M | 25.14M | 4.6M | -624 | 125K | 636.07K |
Current Ratio | 0.70x | 0.59x | 0.86x | 0.08x | 0.18x | 0.18x | 0.23x |
Quick Ratio | 0.70x | 0.59x | 0.84x | 0.08x | 0.15x | 0.18x | 0.21x |
Cash Conversion Cycle | - | - | -83.87 | - | 27.08 | 16.81 | 16.29 |
Total Non-Current Liabilities | 104.3K | 82.95K | 15.02K | 75.11K | 160.91K | 148.55K | 141.48K |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 25.88K | 33.65K | 15.02K | 75.11K | 51.8K | 67.47K | 269.17K |
Deferred Tax Liabilities | 0 | 49.29K | 0 | 0 | 76.7K | 81.08K | 76.7K |
Other Non-Current Liabilities | 78.42K | 0 | 0 | 0 | 32.4K | 0 | 58.7K |
Total Liabilities | 6.2M | 7.4M | 29.14M | 8.79M | 4.3M | 5.98M | 5.85M |
Total Debt | 709.97K | 462.31K | 3.63M | 3.37M | 1.27M | 2.4M | 2.28M |
Net Debt | 459.2K | 272.31K | 3.57M | 3.19M | 1.03M | 2.06M | 2.11M |
Debt / Equity | - | 0.77x | - | - | - | - | -0.61x |
Debt / EBITDA | - | - | - | - | - | - | -1.15x |
Net Debt / EBITDA | - | - | - | - | - | - | -1.06x |
Interest Coverage | -13.58x | 8.46x | -264.57x | -362.18x | -392.00x | -10.92x | -46.56x |
Total Equity | -317.36K▲ 0% | 600.05K▲ 289.1% | -3.51M▼ 684.5% | -7.48M▼ 113.3% | -2.57M▲ 65.6% | -4.27M▼ 65.9% | -3.73M▲ 0% |
Equity Growth % | - | 289.08% | -684.46% | -113.34% | 65.62% | -65.92% | 141.66% |
Book Value per Share | -0.86 | 1.30 | -5.83 | -6.53 | -1.58 | -2.30 | -2.01 |
Total Shareholders' Equity | -360.59K | 521.23K | -3.52M | -7.5M | -2.55M | -4.25M | -3.71M |
Common Stock | 334.86K | 334.86K | 21.31M | 27.43M | 47.81M | 48.83M | 47.83M |
Retained Earnings | -684.5K | 180.33K | -24.7M | -34.74M | -50.1M | -52.87M | -51.3M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -10.96K | 6.04K | -125.69K | -185.47K | -260K | -210.99K | -234.37K |
Minority Interest | 43.23K | 78.82K | 13.48K | 16.61K | -19.01K | -12.58K | -16.75K |
EUDA Cash Flow Statement
EUDA Health Holdings Limited (EUDA) cash flow — operating, investing & free cash flow history
| Metric | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|
Cash from Operations | -411.88K | 443.92K | -1.53M | -2.92M | -2.03M | -2.43M | -1.99M |
Operating CF Margin % | -4.64% | 9.74% | -40.56% | -78.72% | -50.73% | -35.58% | - |
Operating CF Growth % | - | 207.78% | -443.94% | -91.11% | 30.27% | -19.26% | 2.18% |
Net Income | 198.97K | 900.4K | -24.95M | -8.44M | -17.6M | -2.77M | 266.67K |
Depreciation & Amortization | 285.38K | 264.1K | 172.02K | 119.35K | 173.22K | 406.48K | 272.07K |
Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes | -32.27K | -27.68K | -48.23K | 0 | -4.38K | 4.38K | 0 |
Other Non-Cash Items | -85.21K | -1.87M | 22.18M | 4.87M | 15.21M | 160.35K | -2.03M |
Working Capital Changes | -778.75K | 1.18M | 1.12M | 531.2K | 194.93K | -230.03K | -504.54K |
Change in Receivables | 735.82K | -263.95K | -174.82K | -32.97K | 82.35K | -166.99K | -228.79K |
Change in Inventory | 0 | 0 | 3.69M | 0 | -126.27K | 45.43K | -106.94K |
Change in Payables | -791.25K | 1.38M | -1.13M | 1.27K | 15.99K | -12.95K | 0 |
Cash from Investing | 179.34K | -356.18K | -268.21K | 0 | -147.77K | -104.45K | -166.97K |
Capital Expenditures | -76.06K | -1.96K | -18.14K | -5 | -116.03K | -77.26K | -118.83K |
CapEx % of Revenue | 0.86% | 0.04% | 0.48% | 0% | 2.89% | 1.13% | 2.3% |
Acquisitions | 255.41K | -354.23K | -3.4K | 0 | 16.3K | 0 | 552 |
Investments | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | -246.66K | 5 | -48.03K | -27.19K | -48.69K |
Cash from Financing | 212.51K | -168.37K | 2.49M | 2.35M | 2.32M | 2.55M | 1.94M |
Debt Issued (Net) | -5.13K | -6.69K | 1.4M | 1.44M | 2.16M | 2.22M | 0 |
Equity Issued (Net) | 35.11K | 0 | 1.1M | 790K | 50K | 100K | 0 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 182.52K | -161.69K | -9.47K | 121.88K | 115.14K | 234.46K | 1.94M |
Net Change in Cash | -66.85K▲ 0% | -60.77K▲ 9.1% | 594.49K▲ 1078.2% | -586.93K▼ 198.7% | 40.05K▲ 106.8% | 107.54K▲ 168.5% | -390.58K▲ 0% |
Free Cash Flow | -487.94K▲ 0% | 441.96K▲ 190.6% | -1.54M▼ 449.6% | -2.92M▼ 88.9% | -2.15M▲ 26.3% | -2.53M▼ 17.7% | -2.11M▲ 0% |
FCF Margin % | -5.5% | 9.7% | -41.04% | -78.72% | -53.62% | -37.11% | -40.9% |
FCF Growth % | - | 190.58% | -449.57% | -88.86% | 26.29% | -17.68% | -29.48% |
FCF per Share | -1.31 | 0.96 | -2.57 | -2.55 | -1.33 | -1.36 | -1.14 |
FCF Conversion (FCF/Net Income) | -2.35x | 0.51x | 0.06x | 0.29x | 0.13x | 0.88x | -7.91x |
Interest Paid | 66.19K | 110.83K | 19.59K | 17.52K | 55.38K | 6K | 24.26K |
Taxes Paid | 12.58K | 30.18K | 156.34K | 42.9K | 11.63K | 32.16K | 0 |
EUDA Key Ratios
EUDA Health Holdings Limited (EUDA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|
Return on Equity (ROE) | 611.85% | - | - | - | - | -8.47% |
Return on Invested Capital (ROIC) | -82.82% | -913.9% | - | - | - | 100.9% |
Gross Margin | 27.42% | 23.11% | 22.72% | 19% | 43.88% | 22.39% |
Net Margin | 18.97% | -661.06% | -270.86% | -382.87% | -40.65% | 5.17% |
Debt / Equity | 0.77x | - | - | - | - | -0.61x |
Interest Coverage | 8.46x | -264.57x | -362.18x | -392.00x | -10.92x | -46.56x |
FCF Conversion | 0.51x | 0.06x | 0.29x | 0.13x | 0.88x | -7.91x |
Revenue Growth | -48.64% | -17.42% | -1.54% | 8.22% | 70.04% | 30.08% |
Related:EUDA Dividend History·EUDA Revenue History·EUDA Price History·EUDA P/E History·EUDA Financial Ratios·EUDA Institutional Holders
EUDA SEC Filings & Documents
EUDA Health Holdings Limited (EUDA) SEC filings — annual & quarterly reports (10-K, 10-Q)
EUDA Frequently Asked Questions
EUDA Health Holdings Limited (EUDA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
EUDA Health Holdings Limited (EUDA) reported $5.2M in revenue for fiscal year 2025. This represents a 42% decrease from $8.9M in 2020.
EUDA Health Holdings Limited (EUDA) grew revenue by 70.0% over the past year. This is strong growth.
Yes, EUDA Health Holdings Limited (EUDA) is profitable, generating $0.3M in net income for fiscal year 2025 (-40.7% net margin).
Dividend & Returns
EUDA Health Holdings Limited (EUDA) had negative free cash flow of $2.1M in fiscal year 2025, likely due to heavy capital investments.